terazosin has been researched along with Angiogenesis, Pathologic in 3 studies
Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 34 men with benign prostatic hyperplasia (BPH) who have been on terazosin treatment (for the obstructive symptoms) were pathologically diagnosed with prostate cancer following surgery." | 3.71 | Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin. ( Borkowski, A; Isaacs, JT; Jacobs, SC; Keledjian, K; Kim, G; Kyprianou, N, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, SL | 1 |
| Guh, JH | 1 |
| Huang, YW | 1 |
| Chern, JW | 1 |
| Chou, JY | 1 |
| Teng, CM | 1 |
| Tahmatzopoulos, A | 1 |
| Lagrange, CA | 1 |
| Zeng, L | 1 |
| Mitchell, BL | 1 |
| Conner, WT | 1 |
| Kyprianou, N | 2 |
| Keledjian, K | 1 |
| Borkowski, A | 1 |
| Kim, G | 1 |
| Isaacs, JT | 1 |
| Jacobs, SC | 1 |
3 other studies available for terazosin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Identification of apoptotic and antiangiogenic activities of terazosin in human prostate cancer and endothelial cells.
Topics: Adenocarcinoma; Animals; Apoptosis; Endothelium, Vascular; Humans; Male; Mice; Mice, Nude; Neovascul | 2003 |
Effect of terazosin on tissue vascularity and apoptosis in transitional cell carcinoma of bladder.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Carcinoma, | 2005 |
Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Apoptosis; Cell Division; Endothelial Growth | 2001 |